Application of syringaldehyde to preparation of radiocancerogenesis protection drug
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
- Publication Date
- 2015-06-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the application of syringaldehyde in the preparation of radiocarcinogenic protective drugs. Background technique
[0002] The application of nuclear energy in the national economy and military fields is becoming more and more extensive, and the potential harm of ionizing radiation or nuclear radiation to human beings is also increasing. Radiation-induced carcinogenesis is one of the main forms of radiation damage and health hazards. It is a random effect and has a serious impact on human health and life. In some special combat readiness and battlefield environments in the national defense field of our country, such as the army’s underground tunnels, nuclear-powered submarines, the daily installation and maintenance of nuclear weapons of the Second Artillery Force, storage management, special equipment transportation and combat readiness training, there will be a large number of scientific research personnel and training personn...